Pseudomonas strains and their metabolites to control fish diseases
AssigneesT3 Bioscience, LLC, UWM Research Foundation, Inc.
InventorsChing-Hong Yang, Jian Huang
Life of this patent
Estimating the term…
Abstract
The present disclosure concerns methods of using novel bacterial strains of 0617-T307, 0917-T305, 0917-T306, 0917-T307, 0118-T319, 0318-T327, and 0418-T328, the cell broth and novel metabolites produced from the bacterial strains, that can inhibit the growth of a variety of fish pathogens. The methods include use of novel, potent antimicrobial metabolites produced from the strains corresponding to a compound having Formula (I):
Claims21
A method of controlling a fish pathogen and associated disease of a fish, comprising the steps of
- (i) producing a composition from Pseudomonas soli or Pseudomonas mosselii comprising a bacterial metabolite of Formula (I)
- and
- (ii) applying said composition to the fish to inhibit the growth of the fish pathogen and the associated disease on the fish.
A method of controlling a fish pathogen disease, comprising:
- applying a composition comprising between about 1.0×105 and 1.0×109 cfu per mL Pseudomonas bacteria to fish to inhibit the growth of a fish pathogen and an associated disease,
- wherein the Pseudomonas bacteria is selected from the group consisting of Pseudomonas soli and Pseudomonas mosselii.
A method of controlling a pathogen and associated disease of a crustacean or a mollusk comprising the steps of
- (i) producing a composition from Pseudomonas soli or Pseudomonas mosselii comprising a Pseudomonas bacterial metabolite as Formula (I)
- and
- (ii) applying said composition to the crustacean or mollusk to inhibit the growth of the pathogen and the associated disease on the crustacean or mollusk.
Dependencies are inferred from the claim text.